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1. Introduction
The incidence of kidney disease is rapidly increasing worldwide [1], accompanied by wide-
spread research and development resulting in remarkable improvements in the technolo‐
gies used for treatment in end-stage renal disease (ESRD) patients. Polymeric membranes
are  better  at  preventing the transfer  of  pyrogenic  substances  into  the blood stream and
membrane biocompatibilities are much improved [2]. The sharp molecular cut-offs of these
membranes also prevents further loss of albumin during high-dose convective treatment [3].
These membrane technology advancements have been accompanied by the evolution of var‐
ied choices for renal replacement treatment. Particularly, better outcomes achieved by con‐
vective  treatment  have  encouraged  the  use  of  synthetic  membranes  with  high  water
permeability and sieving characteristics in clinical setups worldwide [4, 5].
Maintenance hemodialysis (HD) nevertheless remains a standard protocol for treating ESRD
patients, despite the development of renal replacement modalities. This process is a result
of two physical phenomena that facilitate mass transfer in purifying blood. Diffusion caused
by a concentration gradient between blood and dialysate contributes to the removal of ure‐
mic solutes, particularly small-sized, water-soluble molecules. Excess water and mid-sized
molecules are removed primarily by convective mass transfer, resulting from the transmem‐
brane pressure gradient [6]. Plasma water flow through a membrane leads to the simulta‐
neous movement of a solute through the membranes.  Thus, volume-controlled high-flux
HD adequately clears mid-size solutes without sterile fluid infusion because forward filtra‐
tion exceeding the desired volume removal is compensated for by backfiltration [7], and this
modality can provide a simpler form of dialysis treatment than other treatment methods.
However, although the convective dose delivered during high-flux HD has been shown to
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reduce mortality in patients at risk [8], overall patient survival remains comparable to that
of low-flux HD [9]. This is presumably caused by the limited amount of internal filtration
involved due to limitations imposed by fluid dynamics and the geometric nature of the he‐
modialyzer.
In contrast, hemodiafiltration (HDF) is characterized by a large filtration volume that far
exceeds the desired volume removal. Given that, the dehydration must be corrected in re‐
al time by infusing exogenous sterile replacement fluid. HDF has been reported to deliver
better dialysis outcomes than high-flux HD, because of the improved middle-to-large size
molecular removal,  better control of EPO and inflammation [10-13],  resulting in less pa‐
tient mortality [14, 15]. However, HDF use is limited globally because the requirement of
exogenous fluid infusion raises concerns about water quality, safety and cost. This has led
to modifications of HDF strategies to increase convective mass transfer without the need for
exogenous replacement fluid infusion. This is achieved by spontaneous fluid reinfusion at
a rate that matches convection. Backfiltration and regenerated ultrafiltrate can be the meth‐
ods of spontaneous fluid restoration.
Push/pull strategies have also been examined to increase total filtration volumes without
the exogenous replacement fluid infusion. The push/pull technique uses the entire mem‐
brane as the forward filtration domain for a period of time. However, backfiltration must
accompany the forward filtration to compensate for the fluid depletion that occurred due
to the forward filtration, and as a result, making it necessary to switch the membranes to a
backfiltration domain. In other words, push/pull systems rely on alternate repetitions of for‐
ward and backward filtration during dialysis treatment and the repetitive filtration contrib‐
utes to the increased total filtration volume.
In this chapter, the trials of push/pull-based renal supportive treatments are reviewed in
terms of their technical description, hemodialytic efficacy and applicability for clinical use.
In addition, the fluid management accuracy of the push/pull dialysis method will be dis‐
cussed in depth.
2. Backfiltration and push/pull operation
Precise volume control is  a crucial  pre-requisite in renal replacement therapy. With kid‐
ney malfunction, the accumulation of uremic toxins and surplus water is a consistent fact
in ESRD patients, and appropriate, timely renal supportive treatment must be conducted to
avoid deadly uremic conditions. It has been recently reported that dialysis outcomes are
considerably improved with enhanced convective mass transfer during hemodialysis, and
techniques to maximize the convective volume exchange have been extensively explored.
As the volume depletion exceeds the prescribed amount, it must be promptly compensat‐
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ed. A straightforward way is to infuse sterile fluid after calculating the desired fluid level.
However, the external infusion of sterile dialysate raises concerns like high standard wa‐
ter quality and treatment-related cost. Reverse movement of dialysate within a hemodialyz‐
er has been tried as an alternative approach.
Backfiltration is the phenomenon that dialysate moves into the blood stream across mem‐
branes, in the area where dialysate pressures are higher than hydraulic blood and osmotic
pressures. A pressure drop is inevitable as fluid flows through a cylindrical tube, and blood
and dialysate pressures decrease along the dialyzers. In a normal countercurrent dialysis
setup, because blood and dialysate flow in opposite directions, these pressure drops occur
with opposing gradients, and in some regions hydraulic blood and dialysate pressures over‐
lap. Thus, the sum of hydraulic and osmotic pressures,  termed transmembrane pressure
(TMP), is positive in the proximal region of a hollow fiber dialyzer, and plasma moves to
the dialysate compartment across the membranes (forward filtration). However, fluid move‐
ment occurs in the opposite direction in the distal region because TMP becomes negative,
and backfiltration occurs. This backfiltration compensates for fluid loss in the proximal re‐
gion (Figure 1) [16].
While backfiltration method could provide fluid restoration easily, the amount of forward
filtration in the normal countercurrent dialysis setup is limited, because (1) a small area of
the membranes is used for the filtration inside the hemodialyzer and (2) the increase of pres‐
sure gradients through the hemodialyzer is limited in a particular hemodialyzer geometry
and flow conditions. These limitations have led to investigations for techniques to increase
the blood-to-dialysate pressure gradients. As fluid pressure drop through a cylindrical tube
is proportional to the tube length, but is inversely proportional to the 4th power of tube di‐
ameter, hemodialyzers with reduced fiber diameters or elongated hemodialyzers have been
developed [17-19]. In addition, a unique design for the hemodialyzer was also introduced
[20-22] in which forward and backward filtration regions are separated longitudinally, in‐
stead of horizontally, giving the independent control of blood or dialysate pressures in each
region.
Additionally, push and pull actions were devised for an infusion-free HDF technique. Dif‐
ferently from other methods, forward filtration and backfiltration repeat in the push/pull
technique. During a given period of time, the entire membrane is used as the forward filtra‐
tion domain, as in the HDF method, by regulating blood pressure higher than dialysate.
Thus, the filtration rates necessarily exceed prescribed rates. Immediately after the forward
filtration, the pressure gradients through the hemodialyzer are reversed, the fluid move‐
ment is switched to the opposite direction. This opposite fluid movement compensates for
the excessive fluid loss during the previous filtration phase. The alternate repetition of for‐
ward filtration and backfiltration constitutes a cycle of fluid movement and the difference of
the forward and backward filtration rates, i.e., net-filtration rates, is regulated at the desira‐
ble level.
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3. Push/pull hemodiafiltration
The concept for repetitive use of forward and backward filtration during conventional dialy‐
sis treatments was first introduced in Japan in the early 1980’s, in an effort to simplify the
infusion-free HDF technique, using a serial arrangement of two hemodiafilters [23-25].
However, that system requires a means of repeating backfiltration [26]. Thus, a redundant
dialysate bag is integrated downstream of the hemodialyzer and connected to the dialysate
stream by a bidirectional peristaltic pump [27]. The push/pull action accomplished by this
bi-directional pump alternates the evacuation and replenishment of the bag. During normal
operation, dialysate flow rates upstream and downstream of the hemodialyzer are main‐
tained in balance and the desired volume removal is achieved by a separate ultrafiltration
pump. Therefore, when the bidirectional push/pull pump pulls a portion of dialysate into
the bag (e.g., 70 ml/min for 3 minutes), hydrostatic pressures through the dialysate compart‐
ment decrease, because the dialysate compartment is closed and has a fixed volume, and
Figure 1. Transmembrane Pressure Gradient along Dialyzer Length.
Hemodialysis458
water flux occurs from blood to the dialysate compartment (ultrafiltration) at the same rate
as dialysate removal from the dialysate compartment. Soon after the ultrafiltration com‐
pletes, the pump reverses and pushes the dialysate in the bag into the dialysate stream,
causing a volume overload in the dialysate compartment. The surplus dialysate in the
closed dialysate compartment is then moved to the blood compartment (backfiltration). An‐
other bag and an additional bidirectional peristaltic pump is also integrated into the venous
chamber, and conducts the pulling and pushing of blood, although in this case, the actions
of the blood-side pump are 180O out of phase with those of the dialysate side pump to keep
blood flow returning to the patient constant.
When pure dialysate is pushed into the blood stream, solute concentrations in blood are im‐
mediately equilibrated and decreased by dilution. Soon after, the blood-to-dialysate pres‐
sure gradient reverses from negative to positive, and plasma fluid in blood is forced to move
into the dialysate compartment, which removes various molecules from the plasma. This re‐
petitive ultrafiltration contributes to convective mass transfer and increases the removal of
small-sized (urea) or mid-sized (beta-2-microglobulin) molecules compared to hemofiltra‐
tion (HF) or hemodialysis method, respectively [28]. On the other hand, repetitive backfiltra‐
tion during push/pull HDF prevents volume depletion. In addition, the repetitive
backflushing of dialysate also helps prevent membrane bindings of various blood compo‐
nents [26].
However, the disposable bags and separate bidirectional peristaltic pumps make this unit
notably complicated. To overcome these shortcomings, a double-chamber cylinder pump
was devised. The double cylinder pump includes two independent chambers and a recipro‐
cal piston, and each chamber is connected to either dialysate or the blood stream [29], as
seen in Figure 2. When the piston squeezes the chamber on the dialysate side, the dialysate
compartment, which has a fixed volume, is pressurized and backfiltration begins. At this
time, the chamber on the blood side expands and blood in the venous chamber starts flow‐
ing in the direction of the cylinder pump. Since the blood volume that returns to the blood-
side chamber of the pump is equal to the backfiltration volume, blood flow returning to
patients remains constant. The piston then moves in the opposite direction and squeezes the
blood-side chamber, the dialysate compartment begins to expand, and the dialysate com‐
partment is depressurized, leading to ultrafiltration. However, despite the large amount of
ultrafiltration, blood flow in the venous line is maintained, because the ultrafiltrate removed
in the hemodialyzer is replenished in the venous chamber.
The reciprocating movement of the piston is regulated by pressure differences between the
two chambers of the cylinder pump (i.e., Pb-Pd). The rotation torque of the driving motor
attached to the piston can be adjusted in accord with TMP (i.e., torque = TMPxSxLxsinθ).
Voltage applied to the motor is adjustable, allowing the TMP to be set at 400 mmHg during
forward filtration, but at -400 mmHg during the backward filtration phase. Pressure-control‐
led push/pull HDF can maintain transmembrane pressures at the maximum permissible lev‐
el throughout treatment [30]. In addition, contrary to the original push/pull HDF, in which
one cycle of filtration and backfiltration takes approximate 4~5 minutes, the pressure con‐
trolled push/pull HDF unit can repeat one cycle in1.5~1.7 seconds.
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This optimized use of transmembrane pressure and more frequent alternations of forward
and backward filtration in the revised push/pull HDF unit are obviously accompanied with
a markedly larger total filtration volumes and higher solutes clearances [30]. The push/pull
HDF unit tends to relieve symptoms like arthralgia (joint pain), irritability, pruritus, and in‐
somnia more rapidly than conventional HD mode [27, 31, 32]. Furthermore, the optimal
maintenance of membrane permeabilities by prompt backfiltration has the added benefit of
considerably inhibiting albumin loss while increasing convection and diffusion [33]. Some
albumin loss is unavoidable when using membranes with high water permeabilities and
sieving characteristics [34]. Since convective therapy is based on larger amounts of fluid ex‐
change and solvent drag during fluid exchange occurs randomly, albumin permeation be‐
comes more worrisome during convective treatments [3]. In addition, filtration-induced
elevated albumin concentration at the inner membrane wall also aggravates the albumin
loss [35]. Protein concentration polarization develops quickly after sudden TMP develop‐
ment and the hydraulic permeabilities of the membrane decrease rapidly in about 2 seconds.
However, during push/pull HDF, backward flushing of dialysate takes place within the time
frame required for the protein layer to fully develop (i.e., 1.5~1.7 seconds), and thus, it can
effectively wash out the inner lumen and inhibit excessive albumin leakage [33]. This dialy‐
sate backflushing eventually allows membrane hydraulic capabilities to be better main‐
tained throughout the treatment.
In summary, push/pull HDF was developed in an effort to perform infusion-free, simultane‐
ous HD and HF by using a single hemodialyzer. Thus, it alternates between ultrafiltration
and backfiltration instead of dividing ultrafiltration and backfiltration regions. Pressure-
controlled push/pull HDF can maintain TMPs at maximal levels and the total filtration vol‐
Figure 2. Push/Pull HDF and Double-Chamber Cylinder Pump
Hemodialysis460
umes achieved are far greater than that of any other treatment modality. In addition to the
filtration quantity, repetitive cycles in a shorter time than the time required for a protein lay‐
er to be established ensure superior membrane use throughout treatment, further inhibiting
albumin loss. Push/pull HDF is assumed to be close to pre-dilution mode HDF because the
repetitive dilution exceeds blood flow rates [36]. Even though post-dilution HDF is more ef‐
ficient in terms of solute removal, the substantial amount of total filtration and the optimal
use of membrane offered by the push/pull HDF technique probably translate to outstanding
hemodialytic outcomes. Therefore, a prolonged prospective study on push/pull HDF may
be worthwhile to determine the benefits of this modality versus other forms of convective
renal replacement.
4. Pulse push/pull hemodialysis
Flow patterns have been an obvious research avenue for treatments requiring extracorporeal
blood circulation. Blood pulsation has been accepted, although with controversy, as benefi‐
cial during cardiopulmonary bypass, because it achieves greater perfusion to peripheral ves‐
sels and end-organs [37, 38]. Blood pulsation in a pediatric CRRT animal model delivers
adequate performance over a 2-hour period in terms of ultrafiltration rates and cross-filter
blood pressure drops [39, 40]. It was further found that the pulsatile flow tends to enhance
ultrafiltration rates versus non-pulsatile flow [41, 42], attributable to increased rheological
power of pulsatile flow. However, little evidence is available clinically or experimentally
that explains the efficacy of pulsatile flow on dialysis outcomes. Pulse push/pull HD
(PPPHD) is a convection-enhanced dialysis treatment, using pulsatile devices for blood and
dialysate to achieve the cyclic repetition of forward and backward filtration. During an early
trial, a T-PLS pump (Twin Pulse Life Supporter, AnC Bio Inc., Seoul, Korea) was used as the
pulsatile pump [43]. The T-PLS consists of blood and dialysate sacs, a reciprocating actuator
and a motor-cam assembly [44], with the actuator between the blood and dialysate sacs (Fig‐
ure 3). When the actuator squeezes the blood sac, blood can move forward due to one-way
check valves. At the same time, the dialysate sac expands and is filled with fresh dialysate.
In the same manner, dialysate also moves forward when the sac is squeezed and the blood
sac is filled with blood. These reciprocating movements create pulsatile flow. By setting
their phase difference at 180O degrees, the pushing phases of blood and dialysate pumps al‐
ternate, and TMPs cycle between positive and negative, driving consecutive periods of ul‐
trafiltration and backfiltration.
The hemodialytic efficiencies of PPPHD have been demonstrated, and studies show that
PPPHD substantially improves uremic marker molecules clearance, particularly for mid-
sized molecules (Table 1) [43]. Increased filtration volumes in the PPPHD unit may also be
due to reduced membrane fouling. In an in vivo setup on PPPHD, one cycle of ultrafiltration
and backfiltration took 3 seconds at a pulse frequency of 20 bpm [45]. When ultrafiltration
and backfiltration times were defined as the durations of positive and negative TMPs, re‐
spectively, ultrafiltration and backfiltration times for the PPPHD unit were approximately
1.7 and 1.3 seconds, respectively. Since protein concentration polarization on the blood-side
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membrane develops during forward filtration and is reduced by backfiltration, membrane
convective capacity could be better maintained during PPPHD than during CHD, showing
smaller reductions in post-dialysis hydraulic permeabilities [45].
Figure 3. T-PLS pump for the original PPPHD
Group BPM QB QD
Clearance (ml/min)
BUN Creatinine Vitamin b12 Inulin
CHD - 236±3.6 420±3 161.1±4.3 127.2±3.9 37.5±6.3 25.3±5.1
PPPHD 40 234±3.1 419±3 166.2±3.8 136.9±4.2 55.7±5.0 37.8±3.9
% Increase - - 3.2 7.6 48 49
P-value NS NS 0.053 <0.05 <0.001 <0.001
Table 1. Solutes Clearances. (CHD, conventional high-flux HD; PPPHD, pulse push/pull HD; BPM, beats per minute; QB,
blood flowrate; QD, dialysate flowrate; BUN, blood urea nitrogen; NS, not significant) (Reproduction was permitted by
a publisher)
5. Modified pulse push/pull hemodialysis
Pulsatile circulation of blood and dialysate offers a simple and efficient strategy for the re‐
petitive cycle of filtration and backfiltration. However, blood pulsation during extracorpor‐
eal renal replacement treatment is potentially problematic. Specifically, instant suction
generated by a pulse pump through a narrow catheter may cause blood damage, vessel nar‐
rowing, or vessel collapse. In addition, instantaneous negative pressures generated up‐
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stream of a pulsatile blood pump not only introduce the possibility of circuit aeration, but
could lead to a failure to maintain predetermined blood flow rates [46, 47].
Hence, PPPHD unit was revised, and while many facets of the original PPPHD were re‐
tained, including the alternating water flux across the membrane, blood pulsation was ex‐
cluded. This was achieved by employing dual pulsation in the dialysate stream, that is,
pulsatile devices in the dialysate stream upstream (a dialysate pump) and downstream (an
effluent pump) of the dialyzer [48]. Backfiltration occurs when the sum of the cross-mem‐
brane pressures is negative, but ultrafiltration when the sum is positive. The hydraulic pres‐
sures of blood and dialysate were both manipulated in the original PPPHD, but since blood
pulsation was eliminated, dialysate pressure alone regulates TMP in the revised unit. There‐
fore, the following two assumptions were made; (1) dialysate compartment pressures must
be far higher than blood-side pressures when pure dialysate is forced into the dialyzer, and
(2) dialysate pressures drop to lower than blood pressures during effluent pump expansion.
Given these assumptions, the dialysate and effluent pumps are replaced with a dual pulse
pump [49].
Figure 4. Dual Pulse Pump (DPP). DPP is composed of a base plate, a unidirectional electric motor, a cam, and four
actuators. It contains two separate silicone tubes. Pulsatile flow is generated by squeezing each dialysate and effluent
tubing segments. (A1~A4, actuators 1 to 4; p1~p6, silicone tubing segments at positions 1 to 6, respectively) (Repro‐
duction was permitted by a publisher)
The dual pulse pump (DPP) is a pulsatile device that was developed to eliminate the one-way
valves that are generally required for pulsatile devices to prevent retrograde flow. Instead, time-
delayed tube openings and closings constitutes a cycle of pulse generation (Figure 4). In other
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words, two separate silicone tubes in the DPP are periodically opened or closed. Pulse genera‐
tion with DPP can be described in terms of four phases as determined by cam rotation, which
translates motor rotation to actuator linear displacement. As the cam rotates, the four actua‐
tors periodically push on the tubing segments at the positions shown in Figure 4. Actuator 1 push‐
es on the tubing segments at positions 1 and 6 (p1 and p6) simultaneously, and actuator 3 squeezes
the tubing segments at positions 3 and 4. Actuators 2 and 4 squeeze tubing segments at p 2 and
p5, respectively, and cause the dialysate in the tube to move in the required direction. For pulse
generation by the dialysate pump, as the cam rotates from θ=0° to 90°, the p2 tubing segment
opens and p1 closes, and these processes overlap such that pure dialysate fills p2 tubing. While
p2 expands, p3 remains closed, acting as an upstream valve to prevent retrograde dialysate.
These tube openings and closings are depicted diagrammatically in Figure 5. During the first
phase, with p3 closed, p2 tube openness increases whereas p1 tube openness decreases. Dur‐
ing the 2nd phase (θ=90°~180°), with p1 closed, p2 begins to be squeezed and simultaneously
p3 begins to open, and pure dialysate is driven into the hemodialyzer. Closure of p1 fulfills the
same function as atrioventricular valve closure during left ventricular systole, which prevents
retrograde flow. Likewise, during the 3rd phase (θ=180°~270°), p3 is closed, while p1 and p2 re‐
main closed and in the final phase (θ=270°~360°), p1 is open, and p2 and p3 remain closed in pre‐
paredness for the next filling phase. These time-delayed tube openings and closures constitute
one cycle of pulse generation. In the same manner, effluent pulsations were also generated
through the effluent tube, although in this case, the actions of actuators 1 and 3 were reversed,
and the pulsatile flow pattern was 180O out of phase with that in the dialysate tube.
Figure 5. Changes in DPP Tube Openness at p1~p3 for Dialysate Pump (top) and at p4~p6 for Effluent Pump (bot‐
tom). Tube openness is defined as the ratio of compressed to original tube cross-sectional area. Tube openness at p1
(p6) and p3 (p4) during cycles ranged between 94% and 0%, corresponding to fully opened and completely closed,
respectively. The p2 and p5 had an openness that ranged from 99% to 17%. (p1~p6, tubing segments at positions 1
to 6, respectively, as shown in Figure 4) (Reproduction was permitted by a publisher)
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Theoretically, forward and backward filtration rates during one cycle of PPPHD are identi‐
cal to effluent and dialysate flow rates, respectively. The moment when pure dialysate is
driven to the dialyzer (i.e., during p2 squeezing), the effluent dialysate path is closed at p6.
At the same time, p1 is also closed, and thus, the pure dialysate pushed into dialyzer moves
into the blood stream (backfiltration), because the whole dialysate compartment is fixed and
closed. Immediately after the backfiltration is completed, the effluent tubing (p5) begins to
expand (i.e., p5 expansion during the 3rd phase), and since the dialysate and effluent path‐
ways are still closed at p1 and p6, respectively, dialysate pressures in the hemodialyzer drop
steeply and ultrafiltration takes place at a rate determined by effluent stroke volume.
During experiments using the revised PPPHD, the animals remained stable without any
procedurally related complications. Molecular removals were satisfactory while total pro‐
tein levels, albumin concentrations, and glucose levels were preserved uniformly through‐
out sessions (Table 2) [50]. As stated before, the DPP is additionally characterized by a lack
of valves, which makes the pulsatile device simple and inexpensive, and thus, any medical-
grade silicone tubes can be used as dialysate and effluent sacs. With the exception of small
tubing sections at p1, p3, p4, and p5, most of the tubing is operated non-occlusively, reduc‐
ing the chances of tubing rupture and spallation [51, 52].
PPPHD
(h) aPTT PT WBC Hct TP ALB Glu Ca2+ Na+ K+
0 16±14 6.0±2.6 10.5±6.1 28.5±4.6 5.3±0.4 3.1±0.1 119±7 12.4±0.8 136±5.7 5.7±0.6
1 48±48 3.9±2.1 6.9±2.6 27.8±4.0 5.3±0.4 - - - - -
2 166±149 4.8±1.9 8.0±3.1 28.0±3.6 5.6±0.7 3.1±0.2 111±4 11.5±0.8 134±4.2 5.1±0.6
3 317±220 4.4±1.3 8.7±2.8 28.5±2.9 5.6±0.7 - - - - -
4 205±69 3.8±0.7 9.2±2.7 27.3±3.5 5.3±0.4 3.1±0.2 126±44 10.8±0.5 132±3.1 4.3±0.5
CHD
(h) aPTT PT WBC Hct TP ALB Glu Ca2+ Na+ K+
0 16±6 3.2±1.1 9.3±4.1 30.3±6.8 5.7±0.4 3.2±0.3 124±10 11.7±0.4 138±4.9 5.9±0.2
1 170±93 3.8±0.6 6.9±4.4 27.3±5.5 5.7±0.1 - - - - -
2 232±125 4.5±0.5 7.8±4.8 28.3±6.1 5.6±0.2 3.2±0.3 111±8 11.3±0.3 136±5.5 4.2±2.4
3 154±50 4.3±2.3 7.5±4.2 28.0±5.6 5.5±0.3 - - - - -
4 248±150 6.0±1.6 9.1±4.7 26.3±5.1 5.2±0.3 3.1±0.3 108±10 10.7±0.2 137±5.2 4.9±0.7
Table 2. Physiologic Parameters and Electrolytes Balance during PPPHD and CHD. (aPTT, activated partial
thromboplastin time in sec; PT, prothrombin time in sec; WBC, white blood cell in 103/μl; Hct, hematocrit %; TP, total
protein in g/dl; ALB, albumin in g/dl; Glu, glucose in mg/dl) (Reproduction was permitted by a publisher)
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6. Pulse push/pull hemodialysis with dual piston pump
Pulse push/pull HD is conceptually similar to the push/pull HDF method. Both modalities
were devised to increase total filtration level by alternating forward and backward filtration.
However, the underlying design of PPPHD significantly differs from push/pull HDF. The
supplementary component required to switch from ultrafiltration to backfiltration phases or
vice versa used in push/pull HDF is not needed for PPPHD because the alternating bimodal
pulsation in the dialysate stream creates the cyclic repetition. In addition, the dual pulsatile
device in the PPPHD unit serves as a flow equalizer.
Maintaining pre-determined flow rates and precise volume control are pre-requisites of ex‐
tracorporeal renal replacement treatments for ESRD patients, particularly when using mem‐
branes with high-water permeability. Accordingly, the dual pulsatile pump integrated into
the dialysate stream has been remarkably improved to achieve substantially more accurate
fluid balancing, and the dual pulsation system acting on the PPPHD dialysate compartment
was replaced with a dual piston pump. Figure 6 is a schematic diagram for the PPPHD sys‐
tem as combined with the dual piston pump. This modification allows pulse generation and
push/pull actions to be achieved, not only by the novel design of the piston pump, but also
by the unique control of piston movements offered. As the dialysate piston compresses the
cylinder, pure dialysate is forced into the dialyzer, but at this time, the effluent stream is
functionally closed at the effluent piston pump, thereby increasing dialysate compartment
pressures rapidly and backfiltration occurs (a→b in Figure 7).The effluent piston then begins
to expand and dialysate moves into the effluent cylinder, while the dialysate supply line re‐
mains closed at the dialysate pump. Because of effluent suction, dialysate compartment
pressures fall sharply and water flux from blood lumen to dialysate occurs (b→c). During
the final step (c→a), pure dialysate fills the dialysate cylinder, and simultaneously used dial‐
ysate is drained.
In an in vitro test of PPPHD with the dual piston pump, in which bovine blood was circulat‐
ed, the phenomena of push (backfiltration) and pull (ultrafiltration) were well sustained
throughout, and their levels perfectly balanced those of stroke volumes of the dialysate and
effluent pumps. In addition, dialysate and effluent piston pumps served as a means of con‐
trolling isovolumetic dialysate flow rates upstream and downstream of the dialyzer. Results
showed the balancing error between dialysate and effluent piston pumps was less than
0.09% of total dialysate volume. During the 4-hour session, total dialysate volume supplied
to the dialyzer is 95.8L, and 95.7L of the used dialysate was collected during the same peri‐
od. Furthermore, TMPs clearly cycled positive and negative due to huge fluctuations in hy‐
draulic dialysate pressures (Figure 8). Despite the use of a peristaltic roller pump for blood,
the blood pressures acquired during PPPHD showed an obvious fluctuation which was per‐
fectly synchronized with dialysate pressure pulsation. Generally, peristaltic roller pumps
create small fluctuations in flow and pressure because of the way they squeeze tubing.
However, the blood pressure fluctuations acquired during PPPHD were much larger than
that observed with peristaltic roller pumps during conventional HD, providing clear evi‐
dence of dialysate flux to the blood stream. Hydrostatic dialysate pressures were approxi‐
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mately 620~660 mmHg during the backfiltration phase and -480~-520 mmHg during the
ultrafiltration phase, which correspond to the positive and negative TMPs of 400~420
mmHg and -460~-506 mmHg, respectively.
In addition, the optimal use of transmembrane pressures and enhanced convective mass
transfer translates into a significant increase of molecular removal. Even though no signifi‐
cant difference was observed with respect to clearances of low molecular weight substances,
the inulin clearances were increased significantly for the PPPHD versus the conventional
high-flux HD (CHD) mode. In addition, there is a clear tendency that the proportionate in‐
crease (%increase) of solutes clearances between the PPPHD and CHD was increased as the
molecular weights increase.
PPPHD with the dual piston pump is also versatile and can be easily converted to conven‐
tional high-flux HD mode. Time-controlled piston operations perform the push and pull op‐
erations, but when the two piston movements are synchronized alternately (that is, dialysate
piston compression and effluent piston expansion or dialysate piston expansion and effluent
piston compression occur simultaneously), dialysate passes through the hemodialyzer with‐
out significant volume exchange. In this situation, the two piston pumps serve as a flow
equalizer only and dialysis is largely achieved by diffusive mass transfer.
Figure 6. Circuit Diagram for PPPHD with Dual Piston Pump.
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Figure 7. Three Phases for Push/Pull Generation for the PPPHD with Dual Piston Pump.
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7. Conclusion
Much evidence shows that HDF delivers better dialysis outcomes than high-flux HD, and
these benefits have been attributed to the higher convective doses permitted during HDF. In
addition, advances in water treatment allow ultrapure replacement fluid to be prepared in
real time, which further inhibits the inflammation risk in the ESRD patients [53]. In this
chapter, the author reviews HDF techniques that are based on the push/pull operation.
Push/pull based HDF techniques were derived by considering the time-split phase separa‐
tion, which is based on the notion that the repetitive ultrafiltration contributes to the in‐
crease in the total filtration volume and convective mass transfer. While the push/pull HDF
requires the use of a separate device so that dialysate pressures are regulated instantaneous‐
ly, the pulse push/pull method employs the pulsatile circulation of dialysate and effluent to
effect the repetitive procedures. In addition, the devised dual piston pump in the most ad‐
vanced PPPHD unit not only offers unmatched fluid balancing accuracy, but also the maxi‐
mal permissible level of convective volume exchange, and the entire dialysis system for
PPPHD could be substantially simplified. Based on these features of the devised PPPHD,
the author believes that the PPPHD system should be further improved by being equipped
with features that simplify overall dialysis treatment and enable dialysis to be performed in
free-standing clinics. A dialysis unit equipped with these features may also provide treat‐
Figure 8. Pressure Profiles during PPPHD treatment (mBP, mean blood pressure; mDP, mean dialysate pressure; TMP,
transmembrane pressure defined by mBP-mDP)
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ment alternatives beyond the current thrice weekly 4-hour practice, and perhaps allow even
daily home dialysis for ESRD patients.
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